QTTB
Q32 Bio Inc
8.40$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -888.7% | – | – | – | – | – | – | – | – | -100.0% | – | – | |
| – | +0.0% | -0.8% | -1.6% | – | – | -0.8% | -23.5% | +0.0% | -1.1% | +0.0% | -5.6% | – | |
| – | -888.7% | – | – | – | – | – | – | – | – | -100.2% | – | – | |
| – | +11.7% | +18.0% | +36.3% | +7.0% | -26.5% | -32.4% | -27.6% | -31.1% | -6.8% | -2.9% | +32.3% | – | |
| – | +28.0% | +78.1% | -9.9% | -0.9% | -10.9% | +28.2% | -21.4% | +0.3% | +13.0% | -0.9% | +7.9% | – | |
| – | +15.4% | +33.2% | +20.7% | +5.0% | -22.8% | -15.8% | -25.0% | -17.4% | +3.7% | -1.7% | +17.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -116.8% | – | – | |
| – | – | – | +240.0% | -82.4% | – | – | +0.0% | +0.0% | -33.3% | +0.0% | +300.0% | – | |
| – | – | – | -1,509.0% | – | – | – | – | – | – | -113.2% | – | – | |
| – | +289.2% | -30.4% | +723.3% | +884.5% | -99.9% | – | – | – | – | – | – | – | |
| – | – | – | -1,750.0% | – | – | – | – | – | – | -113.2% | – | – | |
| – | – | – | – | – | – | -280.5% | – | – | – | -113.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.